Aeovian Pharmaceuticals Company

Aeovian Pharmaceuticals is a San Francisco Bay Area-based biopharmaceutical company aiming to discover, develop, and commercialize innovative therapeutics for the treatment of rare and age-related diseases. The company is developing compounds to modulate molecular pathways that address the underlying causes of disease initiation and progression, such as oxidative, cellular and environmental stress. Aeovian Pharmaceuticals was founded in 2012.
Technology: NeuroTech
Industry: Pharmaceuticals
Headquarters: United States
Founded Date: 1-1
Employees Number: 1-10
Funding Status: Early Stage Venture
Investors Number: 7
Total Funding: $37M
Estimated Revenue: $1M to $10M
Last Funding Type: Series D

Visit Website
Register and Claim Ownership